Table 4.
Association of ADHD symptoms score, treatment, nicotine withdrawal symptoms and craving to smoke with smoking abstinence after target quit date (weeks 2, 4 and 6 post-quit).
Basic modela | Basic model plus withdrawal symptoms |
Basic model plus withdrawal and craving |
|
---|---|---|---|
β (s.e.) | |||
Total ADHD symptoms | −0.01 (0.01) | 0.01 (0.01) | 0.004 (0.01) |
OROS-MPH (vs. placebo) | 0.17 (0.34) | 0.02 (0.34) | 0.08 (0.34) |
Withdrawal symptoms | −0.08 (0.03)* | −0.002 (0.04) | |
Craving | −0.79 (0.14)** |
p<0.01,
p<0.0001
Adjusted for age, gender, race, treatment, week of assessment, site, nicotine patch compliance, and osmotic-release oral system methylphenidate (vs. placebo) compliance.
ADHD: attention-deficit/hyperactivity disorder